Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, has expanded its presence in Asia Pacific, adding strategic distribution partners for synthetic DNA (genes, gene fragment, oligo pool product lines) as well as the exome and custom target enrichment product suite for next-generation sequencing.
The synthetic biology and next-generation sequencing markets are growing rapidly in Asia Pacific, and we are now poised to serve customers in Japan, Korea, India, and Hong Kong, said Emily M. Leproust, CEO of Twist Bioscience. Building on our solid foundation in the United States and Europe, we are extending our global footprint by leveraging selected distributors with strong commercial presence and deep ties to our potential customers in these important geographies.
Related to this expansion, Twist Bioscience has entered into distribution agreements with Recenttec K.K. in Japan; DNA Link and its subsidiary LnCBio Inc. in Korea; Premas Life Sciences in India; and, BioArrow Technology Limited in Hong Kong and Macau. Each organization will be responsible for distributing Twist Bioscience’s products in their respective geographies. – Medical Buyer Bureau